Gustav Kiss
Overview
Explore the profile of Gustav Kiss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eschlbock S, Kiss G, Krismer F, Fanciulli A, Kaindlstorfer C, Raccagni C, et al.
Mov Disord Clin Pract
. 2021 Oct;
8(7):1052-1060.
PMID: 34631941
Background: Urological dysfunction in patients with multiple system atrophy (MSA) is one of the main manifestations of autonomic failure. Urodynamic examination is clinically relevant since underlying pathophysiology of lower urinary...
2.
Kessler T, La Framboise D, Trelle S, Fowler C, Kiss G, Pannek J, et al.
Eur Urol
. 2010 Oct;
58(6):865-74.
PMID: 20934242
Context: Treatment of neurogenic lower urinary tract dysfunction (LUTD) is a challenge, because conventional therapies often fail. Sacral neuromodulation (SNM) has become a well-established therapy for refractory non-neurogenic LUTD, but...
3.
Huwyler M, Kiss G, Burkhard F, Madersbacher H, Kessler T
BJU Int
. 2009 Apr;
104(5):646-50.
PMID: 19338551
Objective: To investigate whether prolonged sacral neuromodulation (SNM) testing induces a substantial risk of infection because of the percutaneous passage of the extension wire. Patients And Methods: A consecutive series...
4.
Oeconomou A, Madersbacher H, Kiss G, Berger T, Melekos M, Rehder P
Eur Urol
. 2008 Jun;
54(4):765-75.
PMID: 18571306
Context: The intraprostatic injection of botulinum neurotoxin type A (BoNT-A) is a minimally invasive but still-experimental treatment of lower urinary tract symptoms (LUTS) due to benign prostatic enlargement (BPE) based...
5.
Kessler T, Burkhard F, Madersbacher H, Kofler A, Poewe W, Kiss G
Curr Med Res Opin
. 2007 Dec;
24(2):343-7.
PMID: 18073008
Objective: Prolonged sacral neuromodulation (SNM) testing is more reliable for accurate patient selection than the usual test period of 4-7 days. However, prolonged testing was suspected to result in a...
6.
Kessler T, Lackner J, Kiss G, Rehder P, Madersbacher H
Neurourol Urodyn
. 2006 Sep;
25(7):758-62.
PMID: 16986135
Aims: To investigate whether upper urinary tract function and the need for surgery in patients with myelomeningocele depends on the timing of initiating neurourological management. Patients And Methods: One hundred...
7.
Kessler T, Lackner J, Kiss G, Rehder P, Madersbacher H
Neurourol Urodyn
. 2006 May;
25(4):361-7.
PMID: 16721816
Aims: To investigate whether the initial urodynamic pattern may predict urinary continence and the need for adjunctive incontinence surgery in patients with myelomeningocele. Patients And Methods: One hundred and twenty-three...
8.
Spinelli M, Weil E, Ostardo E, Del Popolo G, Ruiz-Cerda J, Kiss G, et al.
World J Urol
. 2005 Jul;
23(3):225-9.
PMID: 15988594
The use of a new tined lead electrode for sacral neuromodulation (SNS) was evaluated in a European study including 127 patients with chronic voiding dysfunction. The tined lead can be...
9.
Kessler T, Madersbacher H, Kiss G
Eur Urol
. 2005 Apr;
47(5):660-5.
PMID: 15826759
Objective: To assess the effect of prolonged sacral neuromodulation testing using permanent leads comparing the usual evaluation period of 4 to 7 days to a prolonged evaluation period of a...
10.
Kessler T, Madersbacher H, Kiss G
J Urol
. 2004 Dec;
173(1):153-4.
PMID: 15592061
No abstract available.